ICH stability testing guidelines The International Council for Harmonisation (ICH) sets global standards for pharmaceutical stability testing
When the cause cannot be eliminated, treatment for dry mouth focuses on managing symptoms and preventing complications
Proinsulin misfolding is an early event in the progression to type 2 diabetes
Semaglutide (Ozempic/Wegovy): First-line option, acts on 1 receptor (GLP-1) Tirzepatide (Mounjaro): Second-line, acts on 2 receptors (GLP-1 + GIP), effective for patients tolerant to higher semaglutide doses Retatrutide: Most advanced, acts on 3 receptors (GLP-1 + GIP + GCGR), typically reserved for patients who have developed tolerance to tirzepatide Category: Weight Loss Related Products Medication Features Once-weekly injection Weight loss injection by Eli Lilly Active ingredient: Tirzepatide Trials show ~20% body weight loss Available equivalent: Wegovy Mounjaro is a once-weekly weight loss injection containing Tirzepatide and is now licensed for weight loss in the UK
Meal logging provides objective data that helps patients and healthcare providers identify eating patterns that may need adjustment
Others may include TB-500-only arms or NAD+-focused protocols to see how recovery markers respond under different conditions